Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Sema4, |
RCV002256977 | SCV002529961 | likely benign | Hereditary cancer-predisposing syndrome | 2022-02-14 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002256977 | SCV002720449 | likely benign | Hereditary cancer-predisposing syndrome | 2020-01-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV003101403 | SCV003484543 | likely benign | Multiple endocrine neoplasia, type 2 | 2023-08-01 | criteria provided, single submitter | clinical testing |